238 related articles for article (PubMed ID: 10870872)
1. Zaleplon improves sleep without producing rebound effects in outpatients with insomnia. Zaleplon Clinical Study Group.
Fry J; Scharf M; Mangano R; Fujimori M
Int Clin Psychopharmacol; 2000 May; 15(3):141-52. PubMed ID: 10870872
[TBL] [Abstract][Full Text] [Related]
2. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
3. Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group.
Hedner J; Yaeche R; Emilien G; Farr I; Salinas E
Int J Geriatr Psychiatry; 2000 Aug; 15(8):704-12. PubMed ID: 10960882
[TBL] [Abstract][Full Text] [Related]
4. Zaleplon: a review of its use in the treatment of insomnia.
Dooley M; Plosker GL
Drugs; 2000 Aug; 60(2):413-45. PubMed ID: 10983740
[TBL] [Abstract][Full Text] [Related]
5. A double-blind, randomized, comparative study to evaluate the efficacy and safety of zaleplon versus zolpidem in shortening sleep latency in primary insomnia.
Huang YS; Hsu SC; Liu SI; Chen CK
Chang Gung Med J; 2011; 34(1):50-6. PubMed ID: 21392474
[TBL] [Abstract][Full Text] [Related]
6. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
7. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
[TBL] [Abstract][Full Text] [Related]
8. Long-term use of sedative hypnotics in older patients with insomnia.
Ancoli-Israel S; Richardson GS; Mangano RM; Jenkins L; Hall P; Jones WS
Sleep Med; 2005 Mar; 6(2):107-13. PubMed ID: 15716214
[TBL] [Abstract][Full Text] [Related]
9. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
[TBL] [Abstract][Full Text] [Related]
10. Benefit-risk assessment of zaleplon in the treatment of insomnia.
Barbera J; Shapiro C
Drug Saf; 2005; 28(4):301-18. PubMed ID: 15783240
[TBL] [Abstract][Full Text] [Related]
11. Zaleplon: a pyrazolopyrimidine sedative-hypnotic agent for the treatment of insomnia.
Weitzel KW; Wickman JM; Augustin SG; Strom JG
Clin Ther; 2000 Nov; 22(11):1254-67. PubMed ID: 11117652
[TBL] [Abstract][Full Text] [Related]
12. Lack of residual sedation following middle-of-the-night zaleplon administration in sleep maintenance insomnia.
Walsh JK; Pollak CP; Scharf MB; Schweitzer PK; Vogel GW
Clin Neuropharmacol; 2000; 23(1):17-21. PubMed ID: 10682226
[TBL] [Abstract][Full Text] [Related]
13. Clinically important drug interactions with zopiclone, zolpidem and zaleplon.
Hesse LM; von Moltke LL; Greenblatt DJ
CNS Drugs; 2003; 17(7):513-32. PubMed ID: 12751920
[TBL] [Abstract][Full Text] [Related]
14. Treatment of insomnia with zaleplon, a novel sleep medication.
Doghramji PP
Int J Clin Pract; 2001 Jun; 55(5):329-34. PubMed ID: 11452683
[TBL] [Abstract][Full Text] [Related]
15. Safety of zaleplon in the treatment of insomnia.
Israel AG; Kramer JA
Ann Pharmacother; 2002 May; 36(5):852-9. PubMed ID: 11978165
[TBL] [Abstract][Full Text] [Related]
16. [Pharma-clinics. Drug of the month. Zaleplon (Sonata)].
Ansseau M
Rev Med Liege; 1999 Aug; 54(8):705-6. PubMed ID: 10548901
[TBL] [Abstract][Full Text] [Related]
17. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.
Huedo-Medina TB; Kirsch I; Middlemass J; Klonizakis M; Siriwardena AN
BMJ; 2012 Dec; 345():e8343. PubMed ID: 23248080
[TBL] [Abstract][Full Text] [Related]
20. Hypnotic efficacy of zaleplon for daytime sleep in rested individuals.
Whitmore JN; Fischer JR; Storm WF
Sleep; 2004 Aug; 27(5):895-8. PubMed ID: 15453547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]